Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review
Marie‐Aleth Lacaille‐Dubois
Phytomedicine (2019) Vol. 60, pp. 152905-152905
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action
Carlo Pifferi, Roberto González Fuentes, Alberto Fernández‐Tejada
Nature Reviews Chemistry (2021) Vol. 5, Iss. 3, pp. 197-216
Open Access | Times Cited: 181
The use of RNA-based treatments in the field of cancer immunotherapy
Mohammad Chehelgerdi, Matin Chehelgerdi
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 82
Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases
Jingxing Yang, Jen‐Chih Tseng, Guann‐Yi Yu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 423-423
Open Access | Times Cited: 81
Advances in Infectious Disease Vaccine Adjuvants
Jingyi Fan, Shengbin Jin, Lachlan Gilmartin, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1120-1120
Open Access | Times Cited: 72
The Matrix-M™ adjuvant: A critical component of vaccines for the 21 st century
Linda Stertman, Anna-Karin E. Palm, Behdad Zarnegar, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 55
Complete biosynthesis of QS-21 in engineered yeast
Yuzhong Liu, Xixi Zhao, Fei Gan, et al.
Nature (2024) Vol. 629, Iss. 8013, pp. 937-944
Open Access | Times Cited: 38
Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly
Branca Pereira, Xiao‐Ning Xu, Arne N. Akbar
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 133
Biological and Pharmacological Effects of Synthetic Saponins
Yu-Pu Juang, Pi‐Hui Liang
Molecules (2020) Vol. 25, Iss. 21, pp. 4974-4974
Open Access | Times Cited: 123
Natural and Synthetic Saponins as Vaccine Adjuvants
Pengfei Wang
Vaccines (2021) Vol. 9, Iss. 3, pp. 222-222
Open Access | Times Cited: 92
Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives
Angelika Wagner, Birgit Weinberger
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 85
Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression
Irene Y. Cheung, Nai‐Kong V. Cheung, Shakeel Modak, et al.
Journal of Clinical Oncology (2020) Vol. 39, Iss. 3, pp. 215-226
Open Access | Times Cited: 80
Liposomes as Adjuvants and Vaccine Delivery Systems
Daria Tretiakova, Е. Л. Водовозова
Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology (2022) Vol. 16, Iss. 1, pp. 1-20
Open Access | Times Cited: 65
Challenges in the Vaccination of the Elderly and Strategies for Improvement
Gatot Soegiarto, Dewajani Purnomosari
Pathophysiology (2023) Vol. 30, Iss. 2, pp. 155-173
Open Access | Times Cited: 31
Recombinant proteins A29L, M1R, A35R, and B6R vaccination protects mice from mpox virus challenge
Ding Tang, Xiaoke Liu, Jia Lu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 30
Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidate
Marcellus Korompis, Cynthia Voss, Shuailin Li, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants
Sören Reinke, Aneesh Thakur, Cillian Gartlan, et al.
Vaccines (2020) Vol. 8, Iss. 3, pp. 554-554
Open Access | Times Cited: 57
Understanding Structure–Function Relationships of Nanoadjuvants for Enhanced Cancer Vaccine Efficacy
Jia Tan, Binbin Ding, Bo Teng, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 16
Closed Access | Times Cited: 37
Potential Genes Associated with COVID-19 and Comorbidity
Shanshan Feng, Fu-Qiang Song, Wenqiong Guo, et al.
International Journal of Medical Sciences (2022) Vol. 19, Iss. 2, pp. 402-415
Open Access | Times Cited: 37
Neoantigen Vaccines; Clinical Trials, Classes, Indications, Adjuvants and Combinatorial Treatments
Jenni Viivi Linnea Niemi, Aleksandr V. Sokolov, Helgi B. Schiöth
Cancers (2022) Vol. 14, Iss. 20, pp. 5163-5163
Open Access | Times Cited: 36
Saponins: Research Progress and Their Potential Role in the Post-COVID-19 Pandemic Era
Daniel Mieres‐Castro, Freddy Mora
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 348-348
Open Access | Times Cited: 20
Potentials of saponins-based adjuvants for nasal vaccines
Kai Chen, Ning Wang, Xiaomin Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Semi-synthetic terpenoids with differential adjuvant properties as sustainable replacements for shark squalene in vaccine emulsions
Karl J. Fisher, Robert Kinsey, Raodoh Mohamath, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 16
Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell culture
Xiangmin Lv, Jesse Martin, Heather Hoover, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109006-109006
Open Access | Times Cited: 6
The predominant Quillaja Saponaria fraction, QS-18, is safe and effective when formulated in a liposomal murine cancer peptide vaccine
Shiqi Zhou, Yiting Song, Anoop Nilam, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 687-695
Closed Access | Times Cited: 6
Amyloid-β and α-Synuclein Immunotherapy: From Experimental Studies to Clinical Trials
Jacqui Nimmo, Louise Kelly, Ajay Verma, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top